AAS
MED icon

Avantax Advisory Services’s Medifast MED Stock Holding History

Avantax Advisory Services’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,445
Closed -$261K – 1367
2022
Q2 		$261K Buy
+1,445
New +$259K ﹤0.01% 1075
2021
Q1 		– Sell
-1,158
Closed -$227K – 1062
2020
Q4 		$227K Sell
1,158
-3,790
-77% -$670K 0.01% 833
2020
Q3 		$815K Buy
4,948
+315
+7% +$51.9K 0.01% 604
2020
Q2 		$642K Hold
4,633
– – 0.02% 426
2020
Q1 		$290K Buy
4,633
+1,207
+35% +$110K 0.01% 584
2019
Q4 		$376K Buy
3,426
+916
+36% +$88.6K 0.01% 562
2019
Q3 		$258K Buy
+2,510
New +$270K 0.01% 468

Other funds holding MED

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return